Maintenance treatment with varenicline for smoking cessation in patients with schizophrenia and bipolar disorder: a randomized clinical trial. - Wikidata - wikimedia - TriplyDB

Maintenance treatment with varenicline for smoking cessation in patients with schizophrenia and bipolar disorder: a randomized clinical trial.

Maintenance treatment with varenicline for smoking cessation in patients with schizophrenia and bipolar disorder: a randomized clinical trial.

http://www.wikidata.org/entity/Q34014716

about

Nicotine receptor partial agonists for smoking cessation Varenicline for smoking cessation: a narrative review of efficacy, adverse effects, use in at-risk populations, and adherence Orthosteric and Allosteric Ligands of Nicotinic Acetylcholine Receptors for Smoking Cessation Smoking cessation and reduction in people with chronic mental illness Smoking Use and Cessation Among People with Serious Mental Illness Smoking cessation and the cardiovascular patient Risk of neuropsychiatric adverse events associated with varenicline: systematic review and meta-analysis The Past, Present, and Future of Nicotine Addiction Therapy Varenicline as a Cause of Suicidal Outcomes Varenicline Effects on Smoking, Cognition, and Psychiatric Symptoms in Schizophrenia: A Double-Blind Randomized Trial Varenicline and risk of psychiatric conditions, suicidal behaviour, criminal offending, and transport accidents and offences: population based cohort study Treating Smokers in Substance Treatment With Contingent Vouchers, Nicotine Replacement and Brief Advice Adapted for Sobriety Settings nAChR dysfunction as a common substrate for schizophrenia and comorbid nicotine addiction: Current trends and perspectives.Excess mortality in persons with severe mental disorders: a multilevel intervention framework and priorities for clinical practice, policy and research agendas.Rationale and design of a randomized controlled trial of varenicline directly observed therapy delivered in methadone clinics Use of varenicline for smoking cessation treatment in UK primary care: an association rule mining analysis.Tobacco use treatment in primary care patients with psychiatric illness.Varenicline efficacy and safety among methadone maintained smokers: a randomized placebo-controlled trial.An association between the use of hypnotics and quit status in the treatment of nicotine dependence with varenicline in bipolar disorder.AT-1001: a high-affinity α3β4 nAChR ligand with novel nicotine-suppressive pharmacology Varenicline for smoking cessation in people with schizophrenia: systematic review and meta-analysis.Smoking cessation in Asians: focus on varenicline Tobacco use in bipolar disorder Protocol for CHANGE: a randomized clinical trial assessing lifestyle coaching plus care coordination versus care coordination alone versus treatment as usual to reduce risks of cardiovascular disease in adults with schizophrenia and abdominal obesit Treatment of tobacco use disorders in smokers with serious mental illness: toward clinical best practices Design and Synthesis of Nicotinic Acetylcholine Receptor Antagonists and their Effect on Cognitive Impairment.Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for mood disorders.Expanding Cessation Pharmacotherapy Via Videoconference Educational Outreach to Prescribers.Interventions to Address Medical Conditions and Health-Risk Behaviors Among Persons With Serious Mental Illness: A Comprehensive Review.Cancer screening, prevention, and treatment in people with mental illness.The use of peer mentors to enhance a smoking cessation intervention for persons with serious mental illnesses.Cigarette smoking and interest in quitting among overweight and obese adults with serious mental illness enrolled in a fitness intervention.Pharmacotherapy of Co-Occurring Schizophrenia and Substance Use Disorders Cost-effectiveness of smoking cessation treatment initiated during psychiatric hospitalization: analysis from a randomized, controlled trial Nicotine Replacement Therapy as a Maintenance Treatment.Use of Varenicline in Smokeless Tobacco Cessation: A Systematic Review and Meta-Analysis.Abstinence and Use of Community-Based Cessation Treatment After a Motivational Intervention Among smokers with Severe Mental Illness.Drug repurposing and emerging adjunctive treatments for schizophrenia.A combined analysis of worldwide studies demonstrates an association between bipolar disorder and tobacco smoking behaviors in adults.Pharmacological treatment of schizophrenia with comorbid substance use disorder.

P2860

Q24185773-1800ABA8-9146-40F2-8891-39F39482FA1D Q26751374-0D4DF0A0-A206-42AA-B9E3-87FF08AA96FE Q26774830-15E8C57A-452B-4271-B68A-96D32498824A Q26782639-303CEA8A-5FFF-4EFF-B520-3A1D947678F7 Q26785461-155440B8-4886-46CB-8D6D-EFBE38684235 Q28082695-394CEE48-AF6E-494F-994E-D6C127673F8E Q28083649-9F3CD000-0E86-4D7C-A632-7A65F5EF0CCF Q28088508-9400F899-B6BF-4D40-98C3-A637ED14183B Q28255130-13BE46C2-4BD7-4AC6-9096-F644BA18C966 Q28552053-C106A334-3FEB-42D0-9A55-C0DFBBA1A47C Q28646213-3F0060AC-330B-4EDA-BC5B-2FD00680A232 Q29014090-C5C0FA99-A94C-43DB-83BE-91A954AB96CC Q30362464-D1B8E9BE-ACE4-4F42-B47D-028A641BDFE2 Q30379171-9AA11E64-077F-4B9D-8319-91C16EE51033 Q33854297-FE6E77F4-C355-4118-A01B-E87E49FE2B9C Q34318521-ECEA096C-09C5-457C-9A18-371A39E96507 Q34725293-3599D4B4-899D-428D-9792-CA28F82AFD73 Q34992065-9BF6EDB0-716E-4A34-85C1-FD17378385B4 Q35130719-81706F0D-BEAC-4480-A816-59C947D48700 Q35223957-D6C090C7-72C1-46CF-A19F-0AF03D262C04 Q35302795-D912AD8E-6BA5-4093-8A6F-9FB66CC0286C Q35491463-D7BB2B1E-123D-476C-93FD-F3C0515EA856 Q35579231-5A202EE4-6EF7-4B6D-A315-0B987D3454C0 Q35700367-605C747A-2167-432F-B2D6-E066F961AED8 Q35701489-3BB8FA44-7B4F-486E-BD42-70488AD523FE Q35733853-07BEB82E-E287-48A3-A03E-E6988B9FAD04 Q35862776-A185CDF8-2B76-4C28-A435-FF5DF06C96DC Q36087161-B9832BEE-D983-48D3-88D3-6E3F332A99C7 Q36377890-FF533B1C-B90F-486B-91C7-CAF6AE3BAC79 Q36665194-4CF0239B-5745-48C0-999A-7BD6497C8E1A Q36689666-B862FB7E-F206-4A46-92F2-F60F40C1A658 Q36852595-D975925F-3F0F-41CD-BA8E-AB1F027CC1C6 Q36927085-AA4B2186-1715-4740-8303-EAF3288E5AE0 Q37184340-59E9FEFF-B7BA-4457-BB79-20FBD05433C4 Q37461492-369F9840-A9B2-4279-AC88-8A7876376893 Q38342207-E1E25C4B-E38E-4734-A563-A2C35BF448B6 Q38395288-6637C786-1BF2-4F1A-9702-DC3C972C3AA0 Q38417631-7E798599-70A7-42E7-B241-518BF5E997AF Q38559876-E033ABD6-A36B-47FB-AFEE-F3F428685A6F Q38658672-9724E4F0-84A6-4BEF-8247-A182CDBEDEBA

P2860

Maintenance treatment with varenicline for smoking cessation in patients with schizophrenia and bipolar disorder: a randomized clinical trial.

http://www.wikidata.org/entity/Q34014716

description

2014 nî lūn-bûn

@nan

2014 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Maintenance treatment with var ...... : a randomized clinical trial.

@ast

Maintenance treatment with var ...... : a randomized clinical trial.

@en

Maintenance treatment with var ...... : a randomized clinical trial.

@nl

type

label

Maintenance treatment with var ...... : a randomized clinical trial.

@ast

Maintenance treatment with var ...... : a randomized clinical trial.

@en

Maintenance treatment with var ...... : a randomized clinical trial.

@nl

prefLabel

Maintenance treatment with var ...... : a randomized clinical trial.

@ast

Maintenance treatment with var ...... : a randomized clinical trial.

@en

Maintenance treatment with var ...... : a randomized clinical trial.

@nl

P1433

Q34014716-5F6F26A4-28F4-4D48-BA77-AF7839160C68

P1476

Q34014716-764DF92E-03FC-4A06-B31F-F83609F82BE5

P2093

Q34014716-20402181-8EBE-4307-A3B8-503D696AE49E

Q34014716-4970C5C5-D76A-44F5-85CE-B896D5A8942A

Q34014716-911EFD5F-DF47-47D3-B574-3C75133D2BF9

Q34014716-9670B2E3-1A81-4F4C-B169-4BF6837A921D

Q34014716-A5CA0575-CAA5-4E38-93FE-44CAB6AECF9D

Q34014716-DF6F224C-B68F-4AA8-B686-46BFB9DDA213

P2860

Q34014716-0CB42A4D-E022-4848-8C51-1F3D30EF0D09

Q34014716-18771D63-CF42-4F50-937F-C6C6B319F2C6

Q34014716-22018E97-F86B-4C60-AC90-FFD2F62462BC

Q34014716-25E3D6A0-7D98-4587-9F39-EF349813B46E

Q34014716-2E2C3D72-C388-4BA6-9A5C-1A2305D7C070

Q34014716-3AB7D75B-5AA5-46A1-ADE3-27AA1F75DAB9

Q34014716-3CBE08D6-2D63-4FE9-AF06-C7166DD32266

Q34014716-44406D00-9B72-4190-8750-397713914AF2

Q34014716-757EBD7F-4054-4DBF-BEDC-05FED2A13090

Q34014716-7FEAAA91-A9F8-4BB4-AF9B-D1763322706F

P304

Q34014716-3C350093-35B8-408E-9CA0-9417F0513995

P31

Q34014716-00E95A7C-3749-48D9-A881-400394C1D6AE

P356

Q34014716-406A6F36-C867-44B5-949E-D9ABF8FA183E

P407

Q34014716-5B45753B-0CD8-49F5-9BE7-0A6E8BE44D62

P433

Q34014716-B540386B-4D38-4ED9-821E-1AED7BADB9D6

P478

Q34014716-84256BAA-855A-4ED3-937E-001A6FD74C27

P50

Q34014716-3A1B8D6D-1C4A-48C0-8BA4-E3FABC97B213

Q34014716-4A764681-1365-486E-9040-7D7209A9DA6D

Q34014716-7EC3D264-AADB-4D35-82E8-B5D98A7CB8DF

P577

Q34014716-AC1FF720-9F0C-4ADF-BD58-2DD85E34F787

P5875

Q34014716-7D90380F-1145-4D8D-9D99-89060BE7FF2D

P698

Q34014716-D50BFE03-8BF8-44BB-AC22-646FAF6F974F

P921

Q34014716-0208C958-0661-4FBD-AF51-24E2A2CC4853

Q34014716-23C92304-EB1E-4115-8FFC-DAAE431F6694

Q34014716-BA4B9C65-8B1A-44A3-8AF6-E6FB7E843EE0

P932

Q34014716-F9F0BD25-82AB-47BE-A9E2-FAABB4DB17B6

P356

JAMA.2013.285113

P1433

Journal of the American Medical Association

P1476

Maintenance treatment with var ...... r: a randomized clinical trial

@en

P2093

A Eden Evins

http://www.w3.org/2001/XMLSchema#string

Corinne Cather

http://www.w3.org/2001/XMLSchema#string

David A Schoenfeld

http://www.w3.org/2001/XMLSchema#string

David Ayer

http://www.w3.org/2001/XMLSchema#string

Gladys N Pachas

http://www.w3.org/2001/XMLSchema#string

Sarah A Pratt

http://www.w3.org/2001/XMLSchema#string

P2860

Relapse prevention interventions for smoking cessation

Interventions for smoking cessation and reduction in individuals with schizophrenia

A new depression scale designed to be sensitive to change

The Fagerström Test for Nicotine Dependence: a revision of the Fagerström Tolerance Questionnaire

A rating scale for mania: reliability, validity and sensitivity

Effects of moderate-dose treatment with varenicline on neurobiological and cognitive biomarkers in smokers and nonsmokers with schizophrenia or schizoaffective disorder.

Varenicline and suicidal behaviour: a cohort study based on data from the General Practice Research Database.

Varenicline, smoking cessation, and neuropsychiatric adverse events.

Adjunctive varenicline treatment with antipsychotic medications for cognitive impairments in people with schizophrenia: a randomized double-blind placebo-controlled trial

Varenicline for Smoking Cessation in Schizophrenia: Safety and Effectiveness in a 12-Week, Open-Label Trial.

P304

145-154

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1001/JAMA.2013.285113

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

311

http://www.w3.org/2001/XMLSchema#string

P50

Susanne S. Hoeppner

P577

2014-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

259627890

http://www.w3.org/2001/XMLSchema#string

P698

24399553

http://www.w3.org/2001/XMLSchema#string

P921

bipolar disorder

P932

4124884

http://www.w3.org/2001/XMLSchema#string